ID PharmD @MayoClinic Arizona. Bugs, drugs, drums, bikes, and wife. #Stl born and raised. Happy to be here. Views my own.
Phoenix, AZ
Joined November 2020
- Tweets177
- Following187
- Followers269
- Likes403
Very proud of our recent PGY1 pharmacy resident Kaylee Whitenack for getting this through to publication!
Much more to sort out, but albumin appears important for outcomes in MSSA bacteremia.
Small study, but super interesting findings! SNAP might provide more info!
🆕️✨️Impact of Hypoalbuminemia on Clinical Outcomes in Patients Receiving Cefazolin for MSSA Bacteremia #idxposts
journals.sagepub.com/doi/abs…
Dan Ilges retweeted
A study led by Dr. @InfectiousDan Ilges, at Mayo Clinic Arizona found that excluding #Cdifficile from gastrointestinal pathogen panels reduced unnecessary treatments, improved diagnostic accuracy, and caused no delays in diagnosis.
Read more: contagionlive.com/view/exclu…
Dan Ilges retweeted
🆕️⚡️⚡️Quasi-experimental, pre/post, retrospective cohort
Positive impact of a diagnostic stewardship intervention
Following gastrointestinal pathogen panel C. difficile target removal, GIPP orders 🔽 from 3.23 to 2.7 per 1,000 patient visits (P < .001)
cambridge.org/core/journals/…
Dan Ilges retweeted
Evaluation of multisite programmatic bundle to reduce unnecessary antibiotic prescribing for respiratory infections: A retrospective cohort study
✅ Just Accepted
🔓 Open Access
🔗 bit.ly/46ulrhX
via @InfectiousDan @Stevens_AK @AbinashVirkMD @pascalisID
Providers discovering twice daily dosing of cephalexin for simple cystitis.
Nicely done @LisaIDpharmD!
🆕️🔥Retrospective, multicenter, cohort study
Twice daily cephalexin is as effective as four times daily dosing for for the treatment of uncomplicated UTI with a cefazolin-susceptible urine culture #IDXposts academic.oup.com/ofid/articl…
Dan Ilges retweeted
🆕️🔥Retrospective, multicenter, cohort study
Twice daily cephalexin is as effective as four times daily dosing for for the treatment of uncomplicated UTI with a cefazolin-susceptible urine culture #IDXposts academic.oup.com/ofid/articl…
Dan Ilges retweeted
#Breaking the #FDA approved #letermovir (Prevymis) for Preventing #CMV in Adult Kidney Transplant Patients #Merck #IDtwitter #Medtwitter #kidneytwitter
contagionlive.com/view/fda-a…
Dan Ilges retweeted
🆕️⚡️🔥Retrospective cohort study suggests that short (≤10 days) antimicrobial courses had comparable 90-day outcomes as intermediate and prolonged regimens for GN-BSI among immunocompromised patients with neutropenia #IDTwitter @IDdocAdi @BradSpellberg
onlinelibrary.wiley.com/doi/…
Dan Ilges retweeted
With the latest CLSI breakpoints, tobramycin is the only reliable aminoglycoside for Pseudomonas if you ever need one (Susceptible: MIC ≤1)
Amikacin: can still be used for UTI (Susceptible: MIC ≤ 16)
Gentamicin: RIP ☠️
Dan Ilges retweeted
From @seausman, @MsSmallsO et al
Analysis of antimicrobial stewardship intervention acceptance rate at a multisite heath system showed female & male clinicians were equally effective at prospective audit and feedback
📄: doi.org/10.1017/ice.2023.93
Attention #IDtwitter - there’s still time to apply to our ID Rph clin specialist opening! Come work with our wonderful @MayoAZINFDIS team. Provide world-class care in beautiful AZ.
- cocci
- transplant
- stewardship
- research
- teaching
- and more!
fa-euwp-saasfaprod1.fa.ocs.o…
